C252 - Update in Aging and Dementia

Event Time: Friday May 10, 2019 1:00 pm to 3:00 pm
Topic(s): Aging, Dementia, Cognitive, and Behavioral Neurology
Director(s): Gil Rabinovici MD
Description: Research in Alzheimer's disease (AD) and other neurodegenerative dementias is rapidly evolving with the advent of novel diagnostic and therapeutic approaches. This course will provide an update on advances in AD biomarkers and clinical trials, as well as the unique ethical dilemmas posed by the movement towards biomarker-based diagnosis. Teaching will be case-based, with an emphasis on what the practicing neurologist needs to know about these recent advances, some of which have already entered the clinical arena.
Completion Message: Participants should become familiar with neuroimaging and fluid-based biomarkers of AD (and other types of dementia) and their potential clinical utility; understand the ethical dilemmas posed by biomarker-based diagnosis of neurodegenerative diseases; and get an update on the AD drug development pipeline, including clinically meaningful adverse effects associated with drugs being used broadly in clinical trials.
CME Credits: 2
Core Competencies: Patient Care, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement

Ready to register for the 2019 AAN Annual Meeting?

Register Now

Related Courses